Ignite Creation Date:
2025-12-24 @ 12:46 PM
Ignite Modification Date:
2026-01-25 @ 7:54 AM
Study NCT ID:
NCT02614261
Status:
COMPLETED
Last Update Posted:
2022-05-18
First Post:
2015-11-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
Sponsor:
Eli Lilly and Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
15769
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None